当前位置: 首页 > 期刊 > 《昆明医学院学报》 > 20192
编号:13556536
MBOAT7在肝癌组织中的表达及其生物信息学功能分析(3)
http://www.100md.com 2019年4月1日 《昆明医科大学报》 20192
     [9].Ke, R.-s., et al., Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma. 2019.

    [10].Gao, J., et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. 2013. 6(269): p. pl1-pl1.

    [11].Vasaikar, S.V., et al., LinkedOmics: analyzing multi-omics data within and across 32 cancer types. 2017. 46(D1): p. D956-D963.

    [12].Szklarczyk, D., et al., STRING v10: protein–protein interaction networks, integrated over the tree of life. 2014. 43(D1): p. D447-D452.

    [13].Johansen, A., et al., Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features. Am J Hum Genet, 2016. 99(4): p. 912-916.

    [14].Mancina, R.M., et al., The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. Gastroenterology, 2016. 150(5): p. 1219-1230.e6.

    [15].Donati, B., et al., MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Sci Rep, 2017. 7(1): p. 4492., 百拇医药(肖剑寒)
上一页1 2 3